RE: PDMR Dealing,..Bodes well15 May 2020 14:17
And again today . Why the hurry to up his stake. Feels like the forgottan COVID 19 share. Impressive list.
The EpiSwitchä platform has already delivered prognostic and predictive biomarker developments and validations in collaboration with University of Glasgow Professors Iain McInnes and Carl Goodyear, as well as with EMD Serono, Pfizer, Genentech, Roche, Mayo Clinic and Massachusetts General Hospital